Skip to main content
Clinical Trials/ACTRN12615000069550
ACTRN12615000069550
Recruiting
N/A

Efficacy and acceptability of oxygen versus CPAP treatment for people who have obstructive sleep apnoea known to respond to oxygen therapy

A/Prof Peter Catcheside0 sites20 target enrollmentJanuary 27, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Obstructive Sleep Apnoea
Sponsor
A/Prof Peter Catcheside
Enrollment
20
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 27, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof Peter Catcheside

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with obstructive sleep apnoea (OSA)
  • \- Recommended usual care with CPAP treatment by their treating physician
  • \- Demonstrated positive treatment response to one night of oxygen therapy (O2 AHI \<10 /hr with a \=50% reduction compared to the air control night; using modified AHI scoring criteria without SaO2 signal blinding and no desaturation criteria).

Exclusion Criteria

  • \- Smokers (due to risk of fire with home oxygen use)
  • \- Women who are pregnant or who are trying to conceive
  • \- Children and/or young people (i.e. \< 18 years)
  • \- Central sleep apnea (central apnea index \>5 /hr)
  • \- Any relevant significant co\-morbidity including respiratory (COPD) or psychiatric disorders likely to place the patient at higher than normal risk or likely to confound experimental treatment outcomes.
  • \- Physician recommended exclusion
  • \- Patient unable (e.g. language difficulties) or unwilling to consent

Outcomes

Primary Outcomes

Not specified

Similar Trials